Stockreport

Upstream Bio Announces Pricing of Upsized Initial Public Offering

Upstream Bio, Inc.  (UPB) 
PDF WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory disea [Read more]